Valye reports for unlimited access

abrdn Palladium ETF Trust is an exchange-traded fund that holds physical palladium bullion to provide investors with exposure to the price performance of palladium. The Trust issues Shares representing fractional ownership interests backed solely by palladium bullion. It offers a cost-effective and accessible alternative to direct palladium ownership, avoiding the complexities and expenses of physical handling. The Trust's Shares trade on the NYSE Arca and are designed to reflect palladium price movements less Trust expenses. The Trust is sponsored by abrdn ETFs Sponsor LLC, with The Bank of New York Mellon serving as Trustee and ICBC Standard Bank Plc as Custodian. The Trust does not engage in active management or derivatives trading, focusing solely on holding physical palladium.

CVB Financial Corp operates as a community bank primarily serving small and medium-sized businesses and their owners in California. The bank offers a comprehensive suite of financial products including deposit accounts, commercial and consumer loans, SBA loans, real estate and construction financing, equipment leasing, and treasury management services. It also provides wealth management and trust services through its CitizensTrust division. The bank operates 62 banking centers and one loan production office across California, with additional trust offices in Ontario, Newport Beach, and Pasadena. The company converted to a national banking charter in December 2025 and is regulated by the OCC and FDIC. CVB Financial is engaged in a pending merger with Heritage Commerce Corp, which will create a combined entity with approximately $22 billion in assets and over 80 centers in California. The company employs over 1,000 associates and emphasizes leadership development and associate engagement. It operates under a framework of strong regulatory capital requirements and is subject to federal and state banking regulations.

Merchants Bancorp, headquartered in Carmel, Indiana, operates as a diversified bank holding company with a focus on mortgage banking and community banking services. Its Multi-family Mortgage Banking segment specializes in originating and servicing loans for affordable multi-family rental housing and healthcare facilities, including tax credit syndication. The Mortgage Warehousing segment provides asset-based financing to mortgage bankers and non-depository financial institutions, facilitating loan funding until sale in the secondary market. The Banking segment offers retail banking, commercial lending, agricultural lending, SBA lending, and residential mortgage banking primarily in Indiana and select states. The company employs an originate-to-sell model for fixed-rate loans while retaining adjustable-rate loans to manage interest rate risk. Merchants Bancorp emphasizes synergies across its segments and maintains a diversified customer base. It has a strong employee culture and ESG commitments focused on affordable housing and social impact.

MarketAxess Holdings Inc is a global operator of electronic trading platforms specializing in fixed-income securities. The company serves institutional investors and broker-dealers, providing an integrated suite of trading protocols, AI-driven execution tools, data analytics, and post-trade services. Its flagship Open Trading platform facilitates anonymous, all-to-all trading, enhancing liquidity and price discovery. MarketAxess generates revenue mainly from commissions on executed trades and information services derived from proprietary trading data. The company invests heavily in technology innovation, including AI and automation, to improve trading efficiency and client experience. MarketAxess operates in a competitive and regulated environment, with ongoing regulatory changes impacting its operations and requiring continuous adaptation.

abrdn Gold ETF Trust is a U.S.-listed exchange-traded fund designed to provide investors with a cost-effective and accessible means to invest in physical gold bullion. Each Share represents a fractional undivided beneficial interest in the Trust's gold holdings. The Trust holds only physical gold bullion, stored and custodied securely, and does not engage in derivative trading or active management. Shares are created and redeemed in large blocks called Baskets by authorized participants, facilitating liquidity and alignment with the underlying gold value. The Trust's Sponsor manages administrative functions and fees, while the Trustee oversees valuation and custody arrangements. The Trust's objective is to track the price of gold bullion less expenses, offering an alternative to direct physical gold ownership with lower transaction and storage costs. The Trust's Shares trade on the NYSE Arca and are subject to market price fluctuations and potential premiums or discounts relative to net asset value.

ManpowerGroup Inc. operates as a global provider of workforce solutions, offering services that span recruitment and assessment, upskilling and training, career management, outsourcing, and workforce consulting. The company serves a diverse client base including small, medium, and large multinational organizations. Its operations are organized into geographic segments: Americas, Southern Europe, Northern Europe, and Asia Pacific Middle East. The company’s brands—Manpower, Experis, and Talent Solutions—focus respectively on contingent staffing and permanent recruitment, IT professional resourcing, and integrated workforce solutions including recruitment process outsourcing and managed service programs. ManpowerGroup’s business model emphasizes flexibility and innovation to address evolving labor market demands and workforce transformations globally. The company manages working capital carefully due to the timing differences between payroll obligations and accounts receivable collections. It operates in a highly competitive and regulated industry with significant exposure to economic cycles and labor market trends.

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to regenerative therapeutics across immunotherapy, endocrinology, urology, neurology, and orthopedics. The company operates through subsidiaries including Creative Medical Technologies, Inc., ImmCelz, Inc., StemSpine, Inc., and AlloCelz LLC. Its lead clinical asset, CELZ-201 (Olastrocel), is in Phase 1/2 trials for chronic lower back pain with FDA Fast Track designation and for Type 1 diabetes. The company employs three proprietary cell platforms: AlloStem (off-the-shelf donor derived perinatal tissue), ImmCelz (personalized immune cell reprogramming), and iPScelz (induced pluripotent stem cells). It integrates AI into drug development to enhance efficiency and target prioritization. Revenue is generated from disposable stem cell concentration kits, though currently minimal. The company maintains a lean team and strategic partnerships to advance clinical programs and manufacturing under cGMP standards.

Canary Staked SUI ETF operates as an exchange-traded fund, but detailed information about its sector, industry, or country of operation is not publicly disclosed. The fund's financial disclosures are limited, with the latest quarterly SEC filing indicating a net loss and no reported revenue or liquidity metrics. The absence of detailed operational data constrains visibility into its business model and financial health.

AIxCrypto Holdings, Inc. is a Delaware-based company listed on Nasdaq under ticker AIXC. The company focuses on embodied AI and robotics, developing platforms such as RoboShare, a matchmaking platform for on-demand robot rentals launched in June 2026, and the AIxC Hub ecosystem platform, which has seen rapid user adoption with over 500,000 registered wallets in its first week. The company pursues a broader strategy integrating embodied AI with Web3 technologies, including concepts like the Robot Second Life Cycle and ground-air integration for the low-altitude economy. AIxCrypto holds a significant investment in Faraday Future Intelligent Electric, Inc. (FFAI), its majority stockholder and lead investor, through an intermediary entity, exposing it to concentration and counterparty risks. The company maintains liquidity with a current ratio of 3.68 as of June 30, 2026, but reported a net loss of $4.19 million for the quarter. Governance is structured with a five-member board and multiple committees, including independent directors. The company has also engaged consulting services from Aibot US Operation Inc. to support business operations.

Canary Marinade Solana ETF is a Delaware statutory trust established in June 2025 to provide investors with exposure to the Solana (SOL) digital asset. The Trust issues shares representing fractional ownership interests and trades on Nasdaq under the ticker SOLC. It holds SOL tokens and seeks to earn additional SOL through staking on the Solana Network, a decentralized blockchain platform that uses Proof-of-History and proof-of-stake consensus mechanisms. The Trust values its shares daily based on a pricing benchmark derived from major SOL trading platforms. The Trust's operations are governed by a Trust Agreement and supported by a network of service providers including a Sponsor, Trustee, Custodian, and Administrator. The Solana Network supports a growing ecosystem of decentralized applications including DeFi, NFTs, and gaming, and is undergoing upgrades to improve network speed, finality, and validator reward distribution.

El Pollo Loco Holdings, Inc. is a restaurant company operating a network of company-operated and franchise-operated locations primarily in the western United States. The company’s revenue streams include sales from company-operated restaurants, franchise royalties, franchise fees, and advertising fees. The business model includes ongoing restaurant development, remodeling programs, and a loyalty rewards program to drive customer engagement. The company’s financial performance is influenced by seasonal factors, with higher sales typically in the second and third quarters. As of mid-2026, the company operates over 500 restaurants and continues to expand its footprint through new openings and franchise growth.

Rayonier Inc is a company engaged primarily in timberland management and wood products manufacturing, with additional operations in real estate. The company segments its operations geographically and by product lines, including Southern Timber, Pacific Northwest Timber, Wood Products, and Real Estate. Rayonier manages timberlands and produces wood products, leveraging its assets to generate revenue through timber sales, wood product manufacturing, and real estate activities.

Cumberland Pharmaceuticals Inc. operates as a specialty pharmaceutical company dedicated to acquiring, developing, and commercializing branded prescription pharmaceuticals. Its primary markets are hospital acute care, gastroenterology, and oncology, served through targeted sales forces in the U.S. The company’s portfolio includes FDA-approved products such as Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, Vibativ, and Talicia. Cumberland also advances clinical programs, notably Phase II trials for ifetroban in rare and serious diseases. The company leverages co-promotion partnerships and maintains a network of international partners to extend its market reach. Manufacturing is outsourced to third-party suppliers, with recent transitions to new facilities under FDA review. Financially, Cumberland reported modest revenues and net losses in recent quarters, with liquidity metrics indicating near-term funding considerations. The company manages expenses to align with revenues and maintains a revolving line of credit to support operations.

Dune Acquisition Corp II is a Cayman Islands exempted company operating as a Special Purpose Acquisition Company (SPAC). It is registered on Nasdaq with multiple securities including units, Class A ordinary shares, and warrants. The company is an emerging growth company under SEC definitions. It has undergone recent management and board changes and entered into agreements with a new sponsor to facilitate its initial business combination. The company maintains liquidity primarily through cash and cash equivalents, with a current ratio below 1, reflecting its SPAC structure and capital deployment plans.

Immix Biopharma, Inc. is a clinical-stage biotechnology company developing cell therapy treatments, primarily focusing on NXC-201, a CAR-T cell therapy candidate for AL amyloidosis and related diseases. The company’s development efforts include extensive clinical trials such as the NEXICART-2 trial, which has reported promising interim results including a 95% complete response rate. Immix Biopharma has received FDA Breakthrough Therapy Designation for NXC-201, reflecting regulatory recognition of its potential. The company is advancing toward a Biologics License Application submission and has expanded clinical trial sites nationwide. Immix Biopharma finances its operations through equity offerings, including a $150 million underwritten offering in May 2026. The company operates as a single segment and manages its resources accordingly. It faces typical biotechnology industry risks including regulatory approval, clinical trial outcomes, and the need for additional financing.

Affiliated Managers Group, Inc. (AMG) is a global strategic partner to independent investment firms, referred to as Affiliates. AMG invests in these partner-owned firms, which retain operational autonomy and significant equity ownership, while AMG provides strategic resources such as growth capital, product development, capital formation, succession planning, and strategic advisory. AMG's Affiliates manage a diversified portfolio of approximately $942 billion in assets as of June 30, 2026, spanning private markets, liquid alternatives, equities, multi-asset, and fixed income strategies. This diversification enhances earnings stability and supports AMG's ability to reinvest in growth opportunities. AMG's partnership model is designed to magnify the competitive advantages of independent firms while preserving their independence, which differentiates AMG from other strategic paths. The company reported strong financial results in Q2 2026, including increased aggregate fees and net income, driven by asset growth and performance fees primarily in alternative strategies. AMG continues to invest in new and existing Affiliates and strategic capabilities to support long-term value creation [S1][S2].

Goldman Sachs Physical Gold ETF (AAAU) is a New York trust that issues shares representing fractional undivided beneficial interests in physical gold bullion held by the Trust. The gold meets London Good Delivery Standards and is held in allocated and unallocated accounts maintained by JPMorgan Chase Bank, N.A., London branch, acting as custodian. The ETF is sponsored by Goldman Sachs Asset Management, L.P., with The Bank of New York Mellon serving as Trustee. Shares trade on the Cboe BZX Exchange. Authorized Participants, which are registered broker-dealers or financial institutions approved by the Sponsor, transact with the Trust by purchasing or redeeming shares in baskets of at least 25,000 shares. The Trust charges a Sponsor Fee of 0.18% annually on net asset value, subject to a fee cap. The ETF provides investors direct exposure to physical gold bullion, distinguishing it from gold miners or other precious metal ETFs. The Trust does not have employees or officers; operational functions are performed by the Sponsor's authorized officers. The fund's net income and earnings per share for Q2 2026 were negative, reflecting market conditions and fund expenses. Liquidity ratios and other balance sheet details are not disclosed in the latest filings. Recent market commentary compares AAAU favorably on fees and direct bullion exposure against other gold ETFs and precious metal funds.

Cellyan Biotechnology Co., Ltd is a Cayman Islands-incorporated foreign private issuer with principal offices in Hong Kong. The company completed its IPO in January 2025 and is listed on Nasdaq. It operates in the biotechnology sector, though specific industry details are not disclosed. The company reports revenue and net income, with liquidity ratios indicating a current ratio of 2.93 as of September 30, 2025. It faces regulatory compliance challenges related to Nasdaq's minimum bid price requirements.

OKYO Pharma Ltd is a clinical-stage pharmaceutical company engaged in the research and development of novel therapeutics, with a primary focus on Urcosimod, a drug candidate targeting neuropathic corneal pain and other ophthalmic conditions. The company has not yet generated revenue from product sales and relies on funding from equity offerings and convertible loan notes to support its operations. Its business model centers on advancing clinical trials, securing regulatory approvals, and preparing for potential commercialization. The company incurs significant research and development expenses, which decreased to approximately $1.8 million in the year ended March 31, 2026, primarily related to Urcosimod. General and administrative expenses increased to $6.7 million in the same period, reflecting higher option charges, legal, recruitment, and public relations costs. OKYO Pharma reported a net loss of $8.95 million for the year ended March 31, 2026, and held cash and cash equivalents of $4.6 million as of July 31, 2025, with liquidity ratios indicating limited short-term liquidity. The company has received FDA alignment and support for its clinical development programs, including endorsement of Phase 2b/3 trial design and compassionate use authorization for Urcosimod. Leadership changes include the appointment of a new CEO in early 2026. The company anticipates increased expenses as it advances clinical trials, regulatory filings, and prepares for potential commercialization, including expanding infrastructure and personnel.

Avalon Holdings Corporation was established in 1998 as a spin-off from American Waste Services, Inc. It operates two primary business segments: waste management services and golf and related operations. The waste management segment provides hazardous and nonhazardous waste disposal brokerage and management, captive landfill management, and salt water injection well operations, primarily serving industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The golf and related operations segment manages four golf courses and country clubs, a hotel resort with extensive amenities, fitness centers, tennis courts, salon and spa services, and a dermatology center. The company owns and operates multiple subsidiaries and has structured some operations as variable interest entities with investment from accredited investors. Revenue sources include membership dues, greens fees, room rentals, food and beverage sales, and various service fees. Avalon’s headquarters and key properties are located in Ohio and Pennsylvania. The company reported net income and earnings per share for the six months ended June 30, 2026, and maintains liquidity ratios slightly above 1.0 [S1][S2].

RICHTECH ROBOTICS INC. is a technology company founded in 2016, specializing in robotics and AI-enhanced solutions. The company is led by experienced executives with backgrounds in technology, finance, and operations. It has engaged in strategic collaborations, including with Microsoft, to enhance its AI capabilities. The company completed a significant private placement financing in early 2026, strengthening its liquidity position. As of March 31, 2026, the company reported modest revenue and a net loss, with strong liquidity ratios indicating substantial cash and short-term investments relative to liabilities. The company is classified as an emerging growth company and is addressing a material weakness in internal controls over financial reporting through a remediation plan.

The Clorox Company operates globally with a portfolio of trusted consumer and professional brands across cleaning, household, lifestyle, and international segments. Its product offerings include cleaning and disinfecting products, bags and wraps, cat litter, food products, water-filtration, and natural personal care. The company sells primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, and e-commerce channels. Clorox's strategic focus includes innovation, digital transformation, portfolio optimization, and sustainability under its IGNITE strategy. The acquisition of GOJO in 2026 expanded its health and hygiene product lines and B2B market presence. The company faces competitive pressures from national and private label brands and invests in research and development to maintain product leadership. Clorox maintains significant customer concentration with Walmart accounting for over a quarter of sales. The company has a history of dividend payments and recently increased its dividend by 1% in July 2026.

Lam Research Corporation designs, manufactures, and services advanced wafer fabrication equipment used in semiconductor manufacturing. The company’s core technologies include deposition, etch, and clean processes essential for producing integrated circuits with nanoscale precision. Lam Research serves a broad customer base including semiconductor memory, foundry, and integrated device manufacturers. Its products enable customers to build smaller, higher performance semiconductor devices used in mobile, computing, cloud infrastructure, automotive, and data storage applications. The company operates globally with manufacturing, R&D, and support facilities across North America, Asia, and Europe. Revenue is generated primarily from systems sales and customer support services, with significant exposure to the foundry and memory market segments. Lam Research emphasizes research and development to address technology inflections such as 3D device scaling and advanced packaging. The company also maintains a share repurchase program and pays quarterly dividends. Recent financial results show strong revenue growth, margin expansion, and net income improvement, supported by robust demand in the semiconductor industry and AI-related market drivers [S1][S2].

CoastalSouth Bancshares, Inc. operates as a financial institution with a focus on net interest income as a primary revenue source. The company manages interest rate risk through derivative instruments and maintains a conservative approach to equity repurchases, having no stock buyback program as of 2025. Its financial disclosures include detailed net income and earnings per share data for Q2 2026, alongside annual performance metrics through 2025.

BancFirst Corporation is a bank holding company providing commercial banking services along with property and casualty insurance and other financial services. The company’s profitability is sensitive to interest rate changes and monetary policy, as it relies on earning a positive interest spread between its loan and securities portfolio and its funding costs. BancFirst faces liquidity risk due to its dependence on external funding sources such as deposits and borrowings. It maintains an enterprise risk management program addressing various financial and operational risks. Regulatory factors, including consumer protection laws and the Durbin Amendment, impact its noninterest income streams such as interchange fees and service charges. The company has a history of paying dividends, subject to regulatory capital adequacy considerations. BancFirst’s stock experiences lower trading volume relative to larger financial firms and can be volatile. The company’s governance structure includes significant ownership by directors and executive officers, and legal provisions that may deter changes in control.

Bitwise 10 Crypto Index ETF is a Delaware statutory trust that issues shares representing fractional undivided beneficial interests in a portfolio of crypto assets. Its investment objective is to track the Bitwise 10 Large Cap Crypto Index. The Trust completed its conversion to an exchange-traded fund and began trading on NYSE Arca under the ticker BITW in December 2025. The Trust is managed by Bitwise Investment Advisers, LLC, which acts as the Sponsor. The Trust holds a portfolio of crypto assets and maintains a very small cash balance, selling assets as needed to pay management fees and expenses. The Sponsor charges a management fee of 2.5% per annum of the net asset value. The Trust's shares can only be created or redeemed by Authorized Participants following the conversion. The Trust's assets are held with custodians and a prime execution agent under agreements that include liability limitations and indemnification provisions. The Trust is subject to risks including cybersecurity threats, potential loss or theft of crypto assets, insolvency of custodians or execution agents, and market volatility of crypto assets.

Mechanics Bancorp is a banking holding company that operates through its subsidiary, Mechanics Bank. The company completed a merger with HomeStreet Bank in September 2025, which expanded its operations and increased complexity. Mechanics Bancorp offers a range of banking products and services including deposit accounts, trust services, and ATM network fees. The company reported $553.9 million in cash and cash equivalents and net income of $57.7 million for the quarter ended June 30, 2026, with earnings per share of $0.26. The business is concentrated in the Western United States, particularly California, Washington, Oregon, and Hawaii.

SkyWater Technology, Inc. is a publicly traded company with recent SEC filings providing detailed financial data for the quarter ended June 28, 2026. The company reported quarterly revenue of approximately $156 million and a net loss of about $6.4 million. Liquidity ratios indicate current liabilities exceed current assets, with a current ratio of 0.57 and a low cash ratio of 0.04. The company references risk factors disclosed in its 2025 annual report with no material changes noted in the latest quarterly filing. Recent news coverage from primary sources highlights the company's stock activity and market context.

PAMT CORP is a holding company owning subsidiaries engaged in truckload dry van carrier services transporting general commodities across the continental United States, Mexico, and parts of Canada. The company operates through wholly-owned subsidiaries and holds operating authorities through several of them. Its operations are aggregated into a single motor carrier segment that includes truckload services and brokerage/logistics services. The company’s fleet includes company-owned trucks and trailers as well as independent contractor trucks. It employs over 2,300 people including drivers and contractor drivers. PAMT emphasizes providing comprehensive truckload transportation solutions, focusing on high-density traffic lanes, superior customer service, and stringent cost controls. Major customers include General Motors, Ford, and Walmart. The company faces a highly competitive and fragmented industry environment with less than 1% market share. Financially, as of mid-2026, the company reported a net loss and maintains liquidity with a current ratio above 1.3. Litigation risks related to operations and brokerage services are noted.

Cimpress plc operates as a global leader in web-to-print mass customization, providing customized physical marketing products and branded merchandise to millions of businesses. Founded in 1995, Cimpress has grown its revenue from $0.2 billion in 2006 to $3.7 billion in fiscal 2026. The company manages a decentralized portfolio of print mass customization businesses, including well-known brands such as VistaPrint, WIRmachenDRUCK, and Pixartprinting. Its product offerings span marketing materials, signage, promotional products, apparel, packaging, and digital marketing services. Cimpress leverages a proprietary mass customization platform (MCP) that integrates customer-facing and manufacturing technologies to enable efficient, low-volume, personalized production at scale. The company operates approximately 3 million square feet of production space globally and partners with numerous third-party fulfillers. Its business model is considered disruptive in large, fragmented print and promotional markets, enabling affordable, customized products with near mass production efficiency. Cimpress faces intense competition from traditional and online suppliers across multiple product categories and geographies [S1].

Artivion, Inc. develops and markets medical devices and implantable human tissues primarily for cardiac and vascular surgical procedures addressing aortic disease. Its product portfolio includes aortic stent grafts for aneurysms and dissections, On-X mechanical heart valves, surgical sealants such as BioGlue, and preservation services for human tissues. The company operates globally with subsidiaries including JOTEC GmbH in Germany and On-X Life Technologies in Texas. Its strategic focus includes new product development, regulatory approvals for new indications, global market expansion, and business development through acquisitions and licensing. The company faces competition from larger medical device and biopharmaceutical firms and is subject to risks related to international operations, supply chain dependencies, regulatory compliance, and market dynamics.

First Community Bankshares, Inc. operates as a financial holding company with a focus on community banking through its wholly owned subsidiary, First Community Bank. The bank provides a range of financial products and services including deposit accounts, loans, and wealth management through its Trust Division and First Community Wealth Management. The company serves a diverse customer base across Virginia, West Virginia, North Carolina, and Tennessee, with a network of 60 branches following the acquisition of Hometown Bancshares, Inc. in early 2026. The company emphasizes organic growth supplemented by strategic acquisitions and aims to be the bank, employer, and investment of choice in its communities. It employs over 600 full-time employees and maintains a strong focus on employee development and retention. The company is subject to extensive federal and state regulation, including capital adequacy and safety standards, and maintains well-capitalized status under Basel III rules.

George Risk Industries, Inc. (GRI) operates in the design, manufacture, and sale of specialized electronic products including custom keyboards, proximity switches, and security alarm components. The company’s primary revenue driver is its security division, which sells to a broad base of distributors and alarm dealers/installers, with two major distributors accounting for a significant share of sales. GRI emphasizes product customization, quality, and US-based manufacturing to compete against larger competitors. The company invests in research and development both internally and in collaboration with customers, focusing on new product lines such as explosion-proof contacts and wireless monitoring devices. GRI maintains a strong liquidity position and has a history of steady financial performance, with recent increases in sales and net income. The company also pursues operational efficiencies through automation and production workflow improvements, and considers acquisitions to expand its product offerings and market reach.

BIMINI CAPITAL MANAGEMENT, INC. is an SEC-registered investment adviser specializing in managing assets primarily backed by Agency mortgage-backed securities related to single-family residential loans. The company generates most of its revenue from management fees calculated as a percentage of assets under management (AUM). Its business model is sensitive to market fluctuations, client asset values, and investment performance. The company is subject to comprehensive federal and state regulations under the Investment Advisers Act of 1940, which impose significant compliance and operational requirements. It maintains fiduciary duties to its clients and manages conflicts of interest through established policies. The company depends on key investment professionals and client relationships for its success and has recently acquired another investment advisory business, facing integration challenges. Cybersecurity risk management is overseen by the Board and senior management. Financially, as of mid-2026, the company reported modest revenues and net income with a healthy cash position. Legal proceedings include demands from Citigroup related to past mortgage agreements, which the company disputes.

McDonald's Corporation is a leading global restaurant brand operating a system of approximately 46,000 restaurants worldwide, predominantly franchised. The company’s business model centers on delivering consistent, iconic menu offerings such as the Big Mac, Chicken McNuggets, and World Famous Fries, while adapting to local tastes and evolving consumer preferences. McDonald's pursues growth through its McDonald's > NEXT strategy, which focuses on elevating menu quality, enhancing marketing relevance, expanding digital and delivery capabilities, optimizing drive-thru operations, and accelerating restaurant development. The company leverages its extensive real estate portfolio and global scale to support financial strength and shareholder returns. McDonald's operates in three main segments: U.S., International Operated Markets, and International Developmental Licensed Markets & Corporate. The company emphasizes food safety and quality through rigorous supplier standards and audits. Digital initiatives include loyalty programs, mobile ordering, and personalized offers. Financially, McDonald's reported $7.1 billion in revenues and $2.36 billion in net income for Q2 2026, with a strong liquidity position and significant long-term debt. The company continues to invest in technology and organizational efficiency to maintain its market leadership.

Bank First Corporation operates as a community bank holding company headquartered in Manitowoc, Wisconsin. Its wholly-owned subsidiary, Bank First, N.A., offers a wide range of retail and commercial banking products including deposit accounts, various loan types (commercial, real estate, construction, consumer), credit cards, and digital banking services. The bank serves customers primarily in Wisconsin and one county in Illinois through 38 branches. It maintains a diversified loan portfolio with a strong credit culture and comprehensive risk management. The company also holds minority interests in insurance and title companies through subsidiaries. Strategic priorities include capital deployment, asset quality, management efficiency, earnings growth, liquidity maintenance, market risk sensitivity, and information technology enhancements. The bank completed the acquisition of Centre 1 Bancorp in January 2026 and announced a merger agreement with PSB Holdings, Inc. in May 2026, subject to closing conditions. The bank competes with a range of financial institutions including fintech and non-bank lenders, emphasizing its community bank positioning and personalized service.